journal article·2024-10-09

Sulfonated Azocalix[4]arene: A Universal and Effective Taste-Masking Agent

Meng-Meng Chen, Shujie Lin, Ze-Han Wang, Shu-Xin Zhang, Fang-Yuan Chen, Junyi Chen, Dong-Sheng Guo, Qingbin Meng

ACS Applied Materials & Interfaces· Volume 16· Issue 40
Publisher page

Abstract

Many active pharmaceutical ingredients have a specific bitter taste. To enhance patient compliance and treatment efficacy, taste-masking agents are crucial in oral drug formulations. Confronting numerous bitter drug molecules with varied structures, the pharmaceutical field strives to explore and develop universal and effective masking approaches. Here, we reported sulfonated azocalix[4]arene (SAC4A), a universal supramolecular masking agent with deep cavity that provides stronger hydrophobic effect and larger interaction area during recognition, allowing high binding affinity to bitter drug molecules. Moreover, bitter drugs could deeply buried in the cavity, with the bitterness effectively masked. As a result, SAC4A can bind to 16 different bitter drugs with high affinities, encompassing alkaloids, flavonoids, terpenoids, and more, while maintaining high biocompatibility. As anticipated, SAC4A effectively masks the unpalatable bitter taste associated with these drugs. Consequently, SAC4A is a promising universal and effective supramolecular masking agent.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Biochemical Analysis and Sensing Techniques · Advanced Chemical Sensor Technologies · Olfactory and Sensory Function Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Frontiers Science Center for New Organic Matter, Collaborative Innovation Center of Chemical Science and Engineering, Nankai University, Tianjin 300071, China

State Key Laboratory of National Security Specially Needed Medicines, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China

Xinjiang Key Laboratory of Novel Functional Materials Chemistry, College of Chemistry and Environmental Sciences, Kashi University, Kashi 844000, China

Funding

Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Tianshan Innovation Team Plan of Xinjiang Uygur Autonomous Region

References (58)

Show source-provided references
1. 10.1002/adfm.20230499710.1002/adfm.202304997 ↗
2. 10.1016/j.biocel.2016.03.00510.1016/j.biocel.2016.03.005 ↗
3. 10.3389/fphar.2020.58766410.3389/fphar.2020.587664 ↗
4. 10.1016/S0092-8674(00)80705-910.1016/S0092-8674(00)80705-9 ↗
5. 10.1016/j.addr.2014.02.01210.1016/j.addr.2014.02.012 ↗
6. 10.3390/pharmaceutics1402041610.3390/pharmaceutics14020416 ↗
7. 10.2174/156720181466617101314595810.2174/1567201814666171013145958 ↗
8. 10.22270/jddt.v12i3-S.544210.22270/jddt.v12i3-S.5442 ↗
9. 10.1016/j.ejpb.2005.05.00610.1016/j.ejpb.2005.05.006 ↗
10. 10.1016/j.jpba.2017.03.04210.1016/j.jpba.2017.03.042 ↗
11. 10.3390/molecules2819696410.3390/molecules28196964 ↗
12. 10.3311/PPch.2122210.3311/PPch.21222 ↗
13. Qian K. · Prog. Pharm. Sci. · 2016 · 40 · 483
14. 10.3390/pharmaceutics1404078010.3390/pharmaceutics14040780 ↗
15. 10.1016/S1773-2247(04)50001-110.1016/S1773-2247(04)50001-1 ↗
16. 10.1039/C7NR03608F10.1039/C7NR03608F ↗
17. 10.1002/cplu.20230046510.1002/cplu.202300465 ↗
18. 10.1039/D2CC00040G10.1039/D2CC00040G ↗
19. 10.1016/j.cclet.2023.10911910.1016/j.cclet.2023.109119 ↗
20. 10.1021/accountsmr.3c0013010.1021/accountsmr.3c00130 ↗
21. 10.1007/s11426-023-1857-210.1007/s11426-023-1857-2 ↗
22. 10.1021/acs.accounts.3c0058510.1021/acs.accounts.3c00585 ↗
23. 10.1002/adma.20190843510.1002/adma.201908435 ↗
24. 10.1002/adma.20220376510.1002/adma.202203765 ↗
25. 10.1093/chemse/bjp09210.1093/chemse/bjp092 ↗
26. 10.1002/ps.749210.1002/ps.7492 ↗
27. 10.7150/thno.6703610.7150/thno.67036 ↗
28. 10.1002/anie.20240213910.1002/anie.202402139 ↗
29. 10.1002/sstr.20220006710.1002/sstr.202200067 ↗
30. 10.1039/D3MH00018D10.1039/D3MH00018D ↗
31. 10.1016/j.jconrel.2024.03.01710.1016/j.jconrel.2024.03.017 ↗
32. 10.1002/adma.20200771910.1002/adma.202007719 ↗
33. 10.1016/j.cclet.2024.10975210.1016/j.cclet.2024.109752 ↗
34. 10.1016/j.cclet.2023.10916110.1016/j.cclet.2023.109161 ↗
35. 10.1039/c1sc00231g10.1039/c1sc00231g ↗
36. 10.1039/D0CC01841D10.1039/D0CC01841D ↗
37. 10.1016/j.supmat.2022.10002010.1016/j.supmat.2022.100020 ↗
38. 10.31635/ccschem.022.20220185910.31635/ccschem.022.202201859 ↗
39. 10.1002/ange.20231632310.1002/ange.202316323 ↗
40. 10.1002/ange.20161215010.1002/ange.201612150 ↗
41. 10.1016/S0169-409X(98)00052-010.1016/S0169-409X(98)00052-0 ↗
42. 10.1039/c9cp00590k10.1039/c9cp00590k ↗
43. 10.1007/s10847-013-0301-610.1007/s10847-013-0301-6 ↗
44. 10.1039/b820852b10.1039/b820852b ↗
45. 10.1016/j.carbpol.2019.01.01110.1016/j.carbpol.2019.01.011 ↗
46. 10.1007/s10847-017-0704-x10.1007/s10847-017-0704-x ↗
47. 10.1007/s10847-015-0516-910.1007/s10847-015-0516-9 ↗
48. 10.1007/s10847-016-0638-810.1007/s10847-016-0638-8 ↗
49. Ying G. · China Pharmaceuticals · 2010 · 19 · 26
50. 10.3109/1083745090318848510.3109/10837450903188485 ↗
51. 10.1208/s12249-016-0683-z10.1208/s12249-016-0683-z ↗
52. 10.1208/s12249-008-9137-610.1208/s12249-008-9137-6 ↗
53. 10.4314/tjpr.v16i10.710.4314/tjpr.v16i10.7 ↗
54. 10.1023/A:101104162879710.1023/A:1011041628797 ↗
55. 10.1080/10406638.2020.181318110.1080/10406638.2020.1813181 ↗
56. 10.1002/cjoc.20109030610.1002/cjoc.201090306 ↗
57. 10.1016/j.apsb.2017.08.00110.1016/j.apsb.2017.08.001 ↗
58. 10.1016/j.clinthera.2013.06.00710.1016/j.clinthera.2013.06.007 ↗